Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

UnitedHealth Group and Amedisys dropped their request to dismiss a government antitrust lawsuit over the insurer's proposed $3.3 billion acquisition of the home health provider. The companies said ...

Major refugee aid groups sued the Trump administration on Monday over the president's executive order suspending the federal refugee resettlement program and funding for resettlement agencies.

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

Feb. 7 (UPI) --The White House on Friday launched a faith office, one day after another executive order was signed to protect Christians from discrimination. President Donald Trump signed the ...

UnitedHealth Group says the Justice Department’ s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...

The IDS at UMHS requires that investigational and study drugs be ordered on these forms. The medication order forms are tailored to each study, identified by the study title and protocol number ...

Even with the new movie hitting cinemas, the watch order for Attack on Titan is pretty straightforward, but still requires a light amount of hand-holding if you want the full picture. But there ...

Across infinite timelines, this is the only one where you can experience the entire Marvel Cinematic Universe in the perfect order. While you wait for the next superhero spectacle to hit the big ...

UnitedHealth Group and Amedisys, which are currently merging, dismissed their bid to challenge a Department of Justice lawsuit that alleges the transaction would reduce competition in certain markets.